In the present study, we investigated the use of PODXL, BCL7B, ARHGEF4, and ITGB1 as useful markers for the prognosis of postoperative PDAC patients in comparison with tumor size and the TNM staging system. This evidence concerns the gene ARHGEF4 and neoplasm.